HALO logo
halo search icon
Palatin Technologies, Inc.

US$14.02

Price Change Indicator
0.02 (0.143%)
Palatin Technologies, Inc.
PTN · NAS

Palatin Technologies, Inc.

Start Trading PTN for Free

US$14.02

Price Arrow0.02 (0.143%)
29/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusNear Support
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Palatin Technologies, Inc. Overview

PTN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About PTN

icon

Website

Palatin Technologies, Inc.

icon

Telephone

1.609.495.2202

icon

Address

Suite 300, 103 Carnegie Center Drive, Princeton, NJ 08852

Description

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Princeton, NJ.

PTN Price Chart

Key Stats

Market Cap

US$24.95M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 4.51 - 31

Trade Value (12mth)

US$105,453.00

1 week

-2.94%

1 month

-30.7%

YTD

-12.65%

1 year

180.4%

All time high

73625.00

Key Fundamentals

EPS 3 yr Growth

-83.00%

EBITDA Margin

0.00%

Operating Cashflow

-$21m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

NaN

Quick Ratio

0.40

Other Data

Shares Outstanding (Fully Diluted)

4m

HALO Sector

Healthcare

Next Company Report Date

02-Sep-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

PTN Announcements

Latest Announcements

DateAnnouncements
19 May 26
19 May 26
14 May 26
28 April 26
28 April 26

PTN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-110.36-101.16-32.15locklocklock
EPS (Fully Diluted)
 $locklocklocklock-110.36-101.16-32.15locklocklock
Growth
 %locklocklocklock41.88.368.2locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Palatin Technologies, Inc. (PTN:NAS)?
Halo FAQ
The current share price of Palatin Technologies, Inc. (PTN:NAS) is USD$14.02.
What is the 52-week high share price for Palatin Technologies, Inc. (PTN:NAS)?
Halo FAQ
The 52-week high share price for Palatin Technologies, Inc. (PTN:NAS) is USD$31.00.
What is the 52-week low share price for Palatin Technologies, Inc. (PTN:NAS)?
Halo FAQ
The 52-week low share price for Palatin Technologies, Inc. (PTN:NAS) is USD$4.51.
What is the dividend yield for Palatin Technologies, Inc. (PTN:NAS)?
Halo FAQ
Palatin Technologies, Inc. (PTN:NAS) does not pay a dividend.
What was Palatin Technologies, Inc. (PTN:NAS) last dividend payment?
Halo FAQ
Palatin Technologies, Inc. (PTN:NAS) does not pay a dividend.
What is the franking level for Palatin Technologies, Inc. (PTN:NAS)?
Halo FAQ
Palatin Technologies, Inc. (PTN:NAS) has a franking level of 0.00%.
In which sector is Palatin Technologies, Inc. (PTN:NAS) classified?
Halo FAQ
Palatin Technologies, Inc. (PTN:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial